Search

everythinglearnresearchcommunity

for

Search:↓

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Human keratinocytes do not naturally respond to androgens.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

Androgens regulate Sertoli cells and affect fertility through specific receptors and coregulators.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

The Hairless gene is crucial for healthy skin and hair growth.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Male pattern baldness involves hormones and cell signals affecting hair growth.

A mutation in the KRT25 gene causes woolly hair and hair loss.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.